Abstract

Corticosteroid binding globulin (CBG) is the carrier for glucocorticoids in plasma. The protein is believed to keep the steroids inactive and to regulate the amount of free hormone acting on target tissues (free hormone hypothesis). Here, we generated a mouse model genetically deficient for CBG to test the contribution of the carrier to glucocorticoid action and adrenocortical stress response. The absence of CBG resulted in a lack of corticosterone binding activity in serum and in an approximately 10-fold increase in free corticosterone levels in CBG-null mice, consistent with its role in regulation of circulating free hormone levels. Surprisingly, cbg(-/-) animals did not exhibit features seen in organisms with enhanced glucocorticoid signaling. Rather, the mice exhibited increased activity of the pituitary axis of hormonal control, normal levels of gluconeogenetic enzymes, and fatigue, as well as an aggravated response to septic shock, indicating an inability to appropriately respond to the excess free corticosterone in the absence of CBG. Thus, our data suggest an active role for CBG in bioavailability, local delivery, and/or cellular signal transduction of glucocorticoids that extends beyond a function as a mere cargo transporter.

Highlights

  • Corticosteroid binding globulin (CBG) is the major transport protein for glucocorticoids in plasma of mammalian species, with more than 90% of circulating corticosteroid molecules being bound by this carrier [2, 11, 24]

  • Our data suggest an active role for CBG in bioavailability, local delivery, and/or cellular signal transduction of glucocorticoids that extends beyond a function as a mere cargo transporter

  • According to the free hormone hypothesis, CBG provides a reservoir of circulating protein-bound steroids that are biologically inactive, and it regulates the amount of free hormones that are available for entry into target tissues [17]

Read more

Summary

Introduction

Corticosteroid binding globulin (CBG) is the major transport protein for glucocorticoids in plasma of mammalian species, with more than 90% of circulating corticosteroid molecules being bound by this carrier [2, 11, 24]. According to the free hormone hypothesis, CBG provides a reservoir of circulating protein-bound steroids that are biologically inactive, and it regulates the amount of free hormones that are available for entry into target tissues [17]. In line with this hypothesis, the concentration of CBG in human plasma correlates inversely with metabolic clearance rates for cortisol [28] while various stressors decrease CBG expression so as to increase free glucocorticoid levels during physiological stress responses [8, 21, 32]. We generated a mouse model of CBG deficiency and characterized the consequences of the carrier gene defect for the systemic and cellular actions of glucocorticoids

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call